» Articles » PMID: 33363538

Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review

Overview
Journal Front Immunol
Date 2020 Dec 28
PMID 33363538
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The current paradigm of onset and progression of periodontitis includes oral dysbiosis directed by inflammophilic bacteria, leading to altered resolution of inflammation and lack of regulation of the inflammatory responses. In the construction of explanatory models of the etiopathogenesis of periodontal disease, autoimmune mechanisms were among the first to be explored and historically, for more than five decades, they have been described in an isolated manner as part of the tissue damage process observed in periodontitis, however direct participation of these mechanisms in the tissue damage is still controversial. Autoimmunity is affected by genetic and environmental factors, leading to an imbalance between the effector and regulatory responses, mostly associated with failed resolution mechanisms. However, dysbiosis/infection and chronic inflammation could trigger autoimmunity by several mechanisms including bystander activation, dysregulation of toll-like receptors, amplification of autoimmunity by cytokines, epitope spreading, autoantigens complementarity, autoantigens overproduction, microbial translocation, molecular mimicry, superantigens, and activation or inhibition of receptors related to autoimmunity by microorganisms. Even though autoreactivity in periodontitis is biologically plausible, the associated mechanisms could be related to non-pathologic responses which could even explain non-recognized physiological functions. In this review we shall discuss from a descriptive point of view, the autoimmune mechanisms related to periodontitis physio-pathogenesis and the participation of oral dysbiosis on local periodontal autoimmune responses as well as on different systemic inflammatory diseases.

Citing Articles

Computational Studies on Recent Congeners of Fluoroquinolones and Nitroimidazoles for Their Use in Periodontal Therapy.

Natarajan P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4731-S4740.

PMID: 40061649 PMC: 11888705. DOI: 10.4103/jpbs.jpbs_1235_24.


How Will Nanomedicine Revolutionize Future Dentistry and Periodontal Therapy?.

DAmico E, Aceto G, Petrini M, Cinquini C, DErcole S, Iezzi G Int J Mol Sci. 2025; 26(2).

PMID: 39859308 PMC: 11765319. DOI: 10.3390/ijms26020592.


Oral Pathogens' Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer's, Diabetes, and Other Systemic Diseases: A Public Health Crisis-A Comprehensive Review.

Murray P, Coffman J, Garcia-Godoy F Pathogens. 2025; 13(12.

PMID: 39770344 PMC: 11677847. DOI: 10.3390/pathogens13121084.


Inflammation and immune response in the development of periodontal disease: a narrative review.

Lopez-Valverde N, Quispe-Lopez N, Blanco Rueda J Front Cell Infect Microbiol. 2024; 14:1493818.

PMID: 39679199 PMC: 11638196. DOI: 10.3389/fcimb.2024.1493818.


Advances in the study of oral microbiota and metabolism associated fatty liver disease: a systematic review.

Huang M, Zhang X, Zhou R, Song Y, Zhang J, Wu J Front Cell Infect Microbiol. 2024; 14:1491696.

PMID: 39600870 PMC: 11588716. DOI: 10.3389/fcimb.2024.1491696.


References
1.
Li Q, Lin X, Wu Z, He L, Wang W, Cao Q . Immuno-histochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis. Saudi J Kidney Dis Transpl. 2013; 24(4):751-8. DOI: 10.4103/1319-2442.113871. View

2.
Potgieter M, Bester J, Kell D, Pretorius E . The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev. 2015; 39(4):567-91. PMC: 4487407. DOI: 10.1093/femsre/fuv013. View

3.
Song B, Zhang Y, Chen L, Zhou T, Huang W, Zhou X . The role of Toll-like receptors in periodontitis. Oral Dis. 2016; 23(2):168-180. DOI: 10.1111/odi.12468. View

4.
Wade S, Canavan M, McGarry T, Low C, Wade S, Mullan R . Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis. Ann Rheum Dis. 2019; 78(3):350-354. PMC: 6390025. DOI: 10.1136/annrheumdis-2018-214138. View

5.
McCluskey J, Farris A, Keech C, Purcell A, Rischmueller M, Kinoshita G . Determinant spreading: lessons from animal models and human disease. Immunol Rev. 1998; 164:209-29. DOI: 10.1111/j.1600-065x.1998.tb01222.x. View